2017 National Standards for Diabetes Self-Management Education and Support
Joni Beck,Deborah A Greenwood,Lori Blanton,Sandra T. Bollinger,Marcene K. Butcher,Jo Ellen Condon,Marjorie Cypress,Priscilla Faulkner,Amy Hess Fischl,Theresa Francis,Leslie E. Kolb,Jodi Lavin-Tompkins,Janice MacLeod,Melinda D. Maryniuk,Carolé Mensing,Eric A. Orzeck,David D. Pope,Jodi L. Pulizzi,Ardis A. Reed,Andrew S. Rhinehart,Linda Siminerio,Jing Wang +21 more
Reads0
Chats0
TLDR
These Standards provide evidence for all diabetes self-management education providers including those that do not plan to seek reimbursement for DSMES, and identify the need to provide person-centered services that embrace the ever-increasing technological engagement platforms and systems.Abstract:
By the most recent estimates, 30.3 million people in the U.S. have diabetes. An estimated 23.1 million have been diagnosed with diabetes and 7.2 million are believed to be living with undiagnosed diabetes. At the same time, 84.1 million people are at increased risk for type 2 diabetes. Thus, more than 114 million Americans are at risk for developing the devastating complications of diabetes (1).
Diabetes self-management education and support (DSMES) is a critical element of care for all people with diabetes. DSMES is the ongoing process of facilitating the knowledge, skills, and ability necessary for diabetes self-care, as well as activities that assist a person in implementing and sustaining the behaviors needed to manage his or her condition on an ongoing basis, beyond or outside of formal self-management training. In previous National Standards for Diabetes Self-Management Education and Support (Standards), DSMS and DSME were defined separately, but these Standards aim to reflect the value of ongoing support and multiple services.
The Standards define timely, evidence-based, quality DSMES services that meet or exceed the Medicare diabetes self-management training (DSMT) regulations, however, these Standards do not guarantee reimbursement. These Standards provide evidence for all diabetes self-management education providers including those that do not plan to seek reimbursement for DSMES. The current Standards’ evidence clearly identifies the need to provide person-centered services that embrace the ever-increasing technological engagement platforms and systems. The hope is that payers will view these Standards as a tool for reviewing DSMES reimbursement requirements and consider change to align with the way their beneficiaries’ engagement preferences have evolved. Research confirms that less than 5% of Medicare beneficiaries utilize their DSMES benefits (2,3). Changes in reimbursement policies stand to increase DSMES access and utilization, which will result in positive impact to beneficiaries’ clinical outcomes, quality of …read more
Citations
More filters
The effectiveness of the teach-back method on adherence and self-management in health education for people with chronic disease: A systematic review
TL;DR: In this article, a systematic review examined the evidence on using the teach-back method in health education programs for improving adherence and self-management of people with chronic diseases, and concluded that the use of the teachback method showed positive effects in a wide range of health care outcomes although these were not always statistically significant.
Journal ArticleDOI
Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association
Margaret A. Powers,Joan K. Bardsley,Marjorie Cypress,Martha M. Funnell,Dixie Harms,Amy Hess-Fischl,Beulette Hooks,Diana Isaacs,Ellen D. Mandel,Melinda D. Maryniuk,Anna Norton,Joanne Rinker,Linda M. Siminerio,Sacha Uelmen +13 more
TL;DR: Diabetes selfmanagement education and support (DSMES) as mentioned in this paper addresses the comprehensive blend of clinical, educational, psychosocial, and behavioral aspects of care needed for daily self-management and provides the foundation to help all people with diabetes navigate their daily self care with confidence and improved outcomes.
Journal ArticleDOI
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Richard I. G. Holt,Richard I. G. Holt,J. Hans DeVries,Amy Hess-Fischl,Irl B. Hirsch,M. Sue Kirkman,Tomasz Klupa,Barbara Ludwig,Kirsten Nørgaard,Kirsten Nørgaard,Jeremy Pettus,Eric Renard,Jay S. Skyler,Frank J. Snoek,Ruth S. Weinstock,Anne L. Peters +15 more
TL;DR: The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) convened a writing group to develop a consensus statement on the management of type 1 diabetes in adults.
Journal ArticleDOI
Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses
TL;DR: It is indicated that telemedicine has the potential to improve clinical outcomes in patients with diabetes and subgroup-specific effectiveness rates favoring certain intervention and population characteristics were found, and the low GRADE ratings indicate that evidence can be considered as limited.
Journal ArticleDOI
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
Mahmoud Ibrahim,Melanie J. Davies,Ehtasham Ahmad,Firas A Annabi,Robert H. Eckel,Ebtesam M Ba-Essa,Nuha Ali El Sayed,Amy Hess Fischl,Pamela Houeiss,Hinde Iraqi,Ines Khochtali,Kamlesh Khunti,Shabeen Naz Masood,Safia Mimouni-Zerguini,Samad Shera,Jaakko Tuomilehto,Guillermo E. Umpierrez +16 more
TL;DR: The use of the emerging technology and continuous glucose monitoring during Ramadan could help to recognize hypoglycemic and hyperglycemic complications related to omission and/or medication adjustment during fasting; however, the cost represents a significant barrier.
References
More filters
Journal ArticleDOI
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Silvio E. Inzucchi,Richard M. Bergenstal,John B. Buse,Michaela Diamant,Ele Ferrannini,Michael A. Nauck,Anne L. Peters,Apostolos Tsapas,Richard C. Wender,David R. Matthews,David R. Matthews,David R. Matthews +11 more
TL;DR: Properties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus are explored.
Journal ArticleDOI
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Silvio E. Inzucchi,Richard M. Bergenstal,John B. Buse,Michaela Diamant,Ele Ferrannini,Michael A. Nauck,Anne L. Peters,Apostolos Tsapas,Richard C. Wender,David R. Matthews,David R. Matthews,David R. Matthews +11 more
TL;DR: This statement has been written incorporating the best available evidence and, where solid support does not exist, using the experience and insight of the writing group, incorporating an extensive review by additional experts (acknowledged below).
Journal ArticleDOI
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C. Knowler,Sarah E. Fowler,Richard F. Hamman,Costas A. Christophi,Heather J. Hoffman,Anne T Brenneman,J. Brown-Friday,Ronald N. Goldberg,Elizabeth M. Venditti,David M. Nathan +9 more
TL;DR: During follow-up after DPP, incidences in the former placebo and metformin groups fell to equal those in theFormer lifestyle group, but the cumulative incidence of diabetes remained lowest in the lifestyle group.
Journal ArticleDOI
Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))
Silvio E. Inzucchi,Richard M. Bergenstal,John B. Buse,Michaela Diamant,Eleuterio Ferrannini,Matthias Nauck,Anne L. Peters,Apostolos Tsapas,Richard C. Wender,David R. Matthews,David R. Matthews,David R. Matthews +11 more
TL;DR: In this paper, the authors discuss the properties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus, including vildagliptin.
Journal ArticleDOI
The WHO-5 Well-Being Index: a systematic review of the literature.
TL;DR: The review demonstrated that the WHO-5 has high clinimetric validity, can be used as an outcome measure balancing the wanted and unwanted effects of treatments, is a sensitive and specific screening tool for depression and its applicability across study fields is very high.